Just sit tight on this one, if the delisting does occur the IPO price won't be based on ASX values but actual fundamentals.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025